The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
125 jobs Number of planned job losses
Announcement Date
18 November 2019
Employment effect (start)
Foreseen end date
Description
The pharmaceutical manufacturer Corden Pharma announced the opening of a collective dismissal procedure for 125 of the 433 workers currently employed in Sermoneta (province of Latina). Administrative positions should be cut by 116 and 9 position will be cut in production.
The company justified its decision with the difficult economic situation it is facing, with operating losses of over €48 million in 2017 and €21 million in 2018, which require a reduction in the workforce. The previous restructuring plan, negotiated in January 2018 with the trade unions and local institutions, which should have encouraged voluntary exits, did not produce the expected results: indeed, only 58 workers left using the incentives.
Negotiations will last for 75 days, as per the procedure foreseen for collective dismissals.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
